NCT01023139 - "Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention" | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

March 31, 2011

Conditions

Obesity

Interventions

BEHAVIORAL

Sibutramine

During phase 1, sibutramine is given to all participants, 10mg po q day. If they do not meet a change in BMI of at least 2.5%,then the dosage may be increased to 15mg po q day. The main intervention in the study during phase 1 and 2is the behavioral modification

Trial Locations (2)

78234

RECRUITING

Brooke Army Medical Center, San Antonio

RECRUITING

Wilford Hall Medical Center, San Antonio